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Evidence for cytochrome P-450 as a source of catalytic iron in myoglo-
binuric acute renal failure. Iron has been implicated to play an important
role in several models of tissue injury, including myoglobinuric acute renal
failure. In this model, myoglobin released from the injured muscle is
generally accepted as a source of iron. In the present study we measured
the bleomycin-detectable iron (iron capable of catalyzing free radical
reactions) in the kidneys and examined the role of cytochrome P-450 as a
source of catalytic iron in glycerol-induced model of myoglobinuric acute
renal failure. Rats were injected with 50% glycerol (8 mI/kg) i.m. after
overnight water deprivation and sacrificed 24 hours later. There was a
marked and a specific increase in the bleomycin-detectable iron content
accompanied by a marked decrease in the cytochrome P-450 content in
the kidneys of glycerol treated rats. We then examined the effects of two
different cytochrome P-450 inhibitors, cimetidine (with ranitidine as a
control) and piperonyl butoxide. Cimetidine, but not ranitidine, signifi-
cantly prevented the increase of bleomycin-detectable iron in the kidneys
of glycerol-treated rats. The loss of cytochrome P-450 content was
substantially blocked by both inhibitors, cimetidine and piperonyl butox-
ide, but not by ranitidine. Both the inhibitors of cytochrome P-450
provided functional (as measured by BUN and creatinine) and histological
protection against glycerol-induced acute renal failure. Our data thus
demonstrate a marked increase in bleomycin-detectable iron in the
kidneys of glycerol-treated rats. Our data also indicate that inhibitors of
cytochrome P-450 provide protection against glycerol-induced acute renal
failure and that cytochrome P-450 may be a significant source of this iron
in this model of acute renal failure.
The first causative association of acute renal failure with
skeletal muscle injury with release of muscle cell contents,
including myoglobin, into plasma (rhabdomyolysis) was de-
scribed by Bywaters and Beall [1] during the Battle of Britain.
Since then the spectrum of etiologies for rhabdomyolysis,
myoglobinuria and renal failure has been markedly expanded
with both traumatic (natural disasters such as earthquakes,
auto accidents) and more recently, non-traumatic causes being
recognized [2—5].
The most widely used model of myoglobinuric acute renal
failure is produced by intramuscular injection of hypertonic
glycerol [6], which causes muscle injury and exposes the kidney to
a large burden of heme proteins, myoglobin and hemoglobin.
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Indeed, Nath and associates have shown in glycerol-treated rats,
that the kidney mounts a vigorous protective response, namely
induction of heme oxygenase, the enzyme normally charged with
the metabolism of the heme ring [7].
A variety of mechanisms by which myoglobin induces renal
failure have been postulated [2, 6]. Among the suggested mech-
anisms is the role of iron in myoglobinuric acute renal failure [81.
The ease with which iron is reversibly oxidized and reduced, while
essential for its metabolic functions, makes iron potentially haz-
ardous because of its ability to participate in the generation of the
hydroxyl radical (the metal catalyzed Haber-Weiss reaction)
and/or in the generation of the highly reactive iron-oxygen
complexes such as ferry! or perferryl ions [9]. In addition, iron has
been shown to exert toxicity to renal tubular cells independently
of hydroxyl radical generation [10]. A marked increase in plasma
and urinary iron [11], induction of heme oxygenase [7] and
protection by the iron chelator, deferoxamine, against glycerol-
induced acute renal failure provide evidence for the role of iron in
this model of injury [11—1 31.
The current dogma is that myoglobin from the muscle serves as
the important source of iron in glycerol-induced acute renal
failure [8, 11—13]. This is not surprising because myoglobin
released from injured muscles is rich in heme iron. However,
numerous experimental studies have demonstrated that myoglo-
bin has an inconsistent and relatively weak nephrotoxic effect [2,
14]. An alternative or additional potential rich source of iron is
cytochrome P-450 [15], first described to play a role in reperfusion
injury of the rabbit lung [16] and more recently in the kidney [17].
The role of cytochrome P-450 in glycerol-induced acute renal
failure has not been previously examined.
In the present study we first examined whether iron capable of
catalyzing free radical reactions (the bleomycin-detectable iron) is
increased in the kidneys in glycerol-induced acute renal failure. In
vivo most of the iron is bound to heme and non-heme proteins,
and does not directly catalyze the generation of hydroxyl radicals
or a similar oxidant [9]. Gutteridge et a! have described an assay,
based on the use of the antibiotic, bleomycin, to detect iron
complexes capable of catalyzing free radical reactions in biological
samples [9, 18—20]. We also examined the effect of inhibitors of
cytochrome P-450 in glycerol-induced acute renal failure and
examined whether there was evidence to suggest that cytochrome
P-450 may be a significant source of this iron in this model of
acute renal failure.
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Methods
Glycerol-induced acute renal failure
Male Sprague-Dawley rats weighing 200 to 250 g were allowed
free access to rat chow (Purina) but deprived of water overnight
prior to the study. The animals were then injected with 50%
glycerol (8 mI/kg, one half of the volume in each hindlimb muscle)
under ketamine anesthesia (30 mg/kg, i.p.), and then allowed free
access to water [12]. The control animals were also deprived of
water as above except no injections were made. Twenty-four
hours after the glycerol injection, the rats were sacrificed followed
by exsanguination. Blood and kidneys, and a piece of the liver
were obtained for the various measurements.
Bleomycin iron assay
Iron capable of catalyzing free radical reactions was measured
by the bleomycin assay developed by Gutteridge et al [18—20], and
as detailed in our previous study [21]. Briefly, the kidney tissues
were homogenized in Chelex-treated pyrogen-free water, loaded
into a Centriprep-30 which has a cut-off value of 30,000 kDa, and
centrifuged at 4°C for 30 minutes at lSOOxg. The clear ultrafiltrate
was collected and used for bleomycin-detectable iron determina-
tion. All reagents except for the sample under test, were made up
in chelex-treated pyrogen-free water in iron free plastic containers
and shaken with chelex-100 to remove as much contaminating
iron as possible. The reaction mixture contained in order: 0.5 ml
of calf thymus DNA (1 mg/mI), 0.05 ml of bleomycin sulphate (1
mg/mI), 0.1 ml of MgCl2 (50 mM), 0.1 ml of sample, 0.05 ml of HC1
(10mM), 0.1 ml of chelex-treated pyrogen free water and 0.1 ml of
ascorbic acid (8 mM). Sample blanks were identical except that
bleomycin was omitted. Tubes were mixed before and after
addition of ascorbate and then incubated at 37°C for two hours
with shaking. The reaction was stopped by adding 0.1 M EDTA,
and mixed with 1 ml of thiobarbituric acid (1% wt/vol in 50 mM
NaOH) and 1 ml of 25% HCI (vol/vol). This reaction mixture was
then heated at 100°C for 15 minutes, cooled, and the resulting
chromogen measured using spectrophotometer by its absorbance
at 532 nm. A standard curve was prepared using various concen-
trations of FeCl3 in chelex-treated pyrogen free water. The
amount of bleomycin-detectable iron in the test sample was
calculated from the standard curve obtained in each experiment.
Cytochrome P-450 content
Fresh kidney or liver tissue was homogenized in ice-cold
isotonic KC1 (0.15 M). The homogenate was then centrifuged at
15,000 g for 20 minutes at 4°C and the precipitate discarded. The
microsomes were sedimented by centrifugation of the supernatant
at 105,000xg for 60 minutes at 4°C. The firmly packed pellet of
microsomes was resuspended in 0.1 M potassium phosphate buffer
(pH 7.4), usually at a concentration of 10 mg of protein per ml.
Cytochrome P-450 content was measured by the method of
Omura and Sato [22]. In brief, suspensions of microsomes were
diluted to about 1 mg of protein per ml with the assay buffer (0.1
M potassium phosphate buffer, pH 7.25, 20% glycerol, 0.2%
tergitol). After recording the baseline, the sample was reduced
with a few crystals of dithionite, followed by CO bubbling for
about one minute. The CO spectrum difference of reduced
microsomes was measured on a Shimadzu UV-21O1PC spectro-
photometer.
Inhibition of cytochrome P-450
Two different inhibitors of cytochrome P-450 were used. Cime-
tidine has imidazole and cyano groups that inhibit cytochrome
P-450 by interacting with the heme iron [23]. This effect of
cimetidine is specific for P-450 as it does not interact with other
heme enzymes [24]. As a control for cimetidine, ranitidine, which
has three times the H2-receptor blocking activity as cimetidine,
inhibits cytochrome P-450 either weakly or not at all [23, 251.
Piperonyl butoxide, on the other hand, yields a metabolite that
binds to heme iron of cytochrome P-450 [26, 27]. Cimetidine (120
mg/kg) or ranitidine (40 mg/kg) was administered i.p. two hours
prior and three hours following glycerol injection. Piperonyl
butoxide (400 mg/kg) was administered i.p. two hours before
glycerol injection. In preliminary studies, we determined the
ability of these doses to inhibit the cytochrome P-450 activity in
liver and kidney using p-nitroanisole demethylase [28] (data not
shown).
Kidney histology
The kidneys were sectioned and a portion fixed in 10% forma-
un, dehydrated and embedded in paraffin. Sections were cut at 2
tm and stained with periodic acid-Schiff reagent. The slides were
coded and semiquantitative analysis of the kidney sections was
performed without knowledge of the treatment protocol. The
changes seen were limited to the tubulointerstitial areas and
graded as follows: 0—trace, normal or mild tubular cell swelling
and/or vacuolar degeneration; I, areas of tubular epithelial cell
swelling, vacuolar degeneration, necrosis, and desquamation in-
volving < 25% of cortical tubules; II, similar changes involving>
25% but < 50% of cortical tubules; III, similar changes involving
> 50% but < 75% of cortical tubules; IV, similar changes
involving > 75% of cortical tubules [12, 291.
Other assays
Plasma urea nitrogen, creatinine and aldolase were measured
by use of Sigma diagnostic kits. Protein was measured by Bio-Rad
assay reagent.
Statistical analysis
Values are expressed as mean standard error. Statistical
analyses were performed using unpaired t-test (for only two
groups) and analysis of variance (for more than two groups).
Statistical significance was considered at P value < 0.05.
Results
Renal function was significantly impaired in rats subjected to
glycerol injection as measured by plasma urea nitrogen and
plasma creatinine (Fig. 1A). A marked increase in the level of
bleomycin-detectable iron in the kidneys was observed in rats
treated with glycerol, as shown in Figure lB. The increase in the
bleomycin-detectable iron content was specific to the kidneys as
there was no difference in the level of this iron in the liver between
the control and glycerol treated group of rats (Fig. 1). We also
examined the effect of glycerol-induced acute renal failure on the
levels of cytochrome P-450. There was a marked decrease in
cytochrome P-450 content (Fig. 2) in the kidneys of rats treated
with glycerol. This loss of cytochrome P-450 was specific to the
kidneys as there was no difference in the level of P-450 content in
the liver between the untreated and treated animals (Fig. 2).
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Fig. 2. Cytochrome P-450 content in the kidneys and in the liver in glycerol
treated rats. Values are means SE. N = 5, *p < 0.05 comparing
glycerol-treated rats with control animals.
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Fig. 1. Glycerol-induced acute renal failure. A. Renal function as measured
by plasma urea nitrogen and plasma creatinine. B. Bleomycin-detectable
iron content in the kidneys and in the liver. Values are means SE. N =
5 *JJT < 0.01 comparing glycerol-treated rats with control animals.
We postulated that the heme moiety of cytochrome P-450 may
serve as a significant source of catalytic iron in this model of
injury. We therefore examined the effect of cimetidine, which
inhibits cytochrome P-450 by interacting with the heme iron [24],
on bleomycin-detectable iron in glycerol-treated rats. In glycerol
injected rats the bleomycin detectable iron increased to 0.80
0.08 (N = 5) from a control value of 0.23 0.04 (N = 5),
representing a mean increase of 0.57 nmol/mg protein. Cimetidine
significantly prevented the increase in bleomycin-detectable iron
content (mean increase 0.18 compared to a mean increase of 0.57
nmol/mg protein) in the kidneys in rats subjected to glycerol
injection (Fig. 3). In contrast, ranitidine, which has a similar
structure as cimetidine but inhibits cytochrome P-450 either
weakly or not at all, did not prevent the marked increase in the
bleomycin-detectable iron in the kidneys (Fig. 3).
One would anticipate that if the heme moiety of cytochrome
P-450 serves as a source of this iron, then inhibitors that prevent
the increase in the bleomycin-detectable iron should also prevent
the loss of cytochrome P-450 in this model. Therefore, we also
measured the effect of these inhibitors on cytochrome P-450
content in glycerol-treated rats. Cimetidine completely prevented
0.0
Fig. 3. Effect of cimetidine (CM) and ranitidine (RN, used as a control) on
the bleomycin-detectable iron content in the kidneys in glycerol treated rats.
The assay was performed in five rats from each group. Values are means
SE. N = 5, 'P < 0.01 compared with glycerol treatment alone.
the decrease in the level of cytochrome P-450 content in the
kidneys of rats subjected to glycerol injection, whereas ranitidine
had little effect (Fig. 4). A second inhibitor of cytochrome P-450,
piperonyl butoxide, also preserved the cytochrome P-450 content
in the kidneys in this model of renal injury (Fig. 4). Taken
together, these data demonstrate that there is an increase in
bleomycin-detectable iron in glycerol-treated rats, and suggests
that cytochrome P-450 may be a source of this iron.
The potential role of cytochrome P-450 in glycerol-induced
acute renal failure has not been previously examined. Based on
our data that these inhibitors of cytochrome P-450 significantly
reduce bleomycin-detectable iron, we examined the effects of
these inhibitors on glycerol-induced acute renal failure. As shown
in Figure 5, the cytochrome P-450 inhibitor, cimetidine, substan-
tially decreased the plasma urea nitrogen and plasma creatinine
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Fig. 4. Effect of cytochrome P-450 inhibitors on cytochrome P-450 content
in the kidneys of glycerol-treated rats. Values are means 5E.N = 5, *JJ <
0.01 compared with glycerol treatment alone. Abbreviations are: CM,
cimetidine; PB, piperonyl butoxide; RN, ranitidine.
compared to rats treated with glycerol alone. In contrast, raniti-
dine did not show any protection (Fig. 5). A second inhibitor of
cytochrome P-450, piperonyl butoxide, provided a similar preser-
vation of renal function in this model of renal injury (Fig. 6).
We also examined the histological changes in the kidney tissue
obtained from five rats in each of the three groups (control,
glycerol alone, and glycerol + cimetidine). Renal function studies
in these subsets were not different from the overall experimental
groups: (a) control: plasma urea nitrogen 15 2, creatinine 0.6
0.04; (b) glycerol alone: plasma urea nitrogen 89 11, creatinine
3.4 0.56; (c) glycerol + cimetidine: plasma urea nitrogen 41
6, creatinine 1.9 0.13 mg/dl. The histological changes were
graded as described in the Methods and the results expressed in
Table 1. In rats treated with glycerol alone there was extensive
epithelial cell vacuolization, swelling, desquamation and necrosis
(grade IV) occurring predominantly in the proximal convoluted
tubules (Fig. 7B) and as described in our previous studies [12, 29].
However, rats treated with cimetidine had a marked reduction in
the extent of tubular damage (Fig. 7C).
We considered the possibility that the protective effect of the
cytochrome P-450 inhibitors may be related to their ability to
prevent glycerol-induced muscle injury. We therefore measured
serum aldolase levels in control, glycerol-treated, and rats that
received the cytochrome-P450 inhibitors in addition to glycerol.
The assay was performed in five rats from each group. Renal
function in these subsets was not different from the overall
experimental groups [(a) control: plasma urea nitrogen, 15 2,
creatinine, 0.6 0.05; (b) glycerol: 88 15, creatinine, 3.1 0.51;
(c) glycerol + cimetidine: plasma urea nitrogen, 40 4, creati-
nine, 1.9 0.09; (d) glycerol + piperonyl butoxide: plasma urea
nitrogen, 52 3, creatinine, 2.0 0.18). As shown in Figure 8, the
protective effect of cytochrome P-450 inhibitors did not appear to
be due to their ability to reduce glycerol-induced muscle damage.
Discussion
Several studies suggest an important role of iron in myoglobin-
uric acute renal failure [7, 11—13]. In the present study we
N=1 0
3:.
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Fig. 5. Effect of cytochrome P-450 inhibitors on glycerol-induced acnte renal
failure as measured by (A) plasma urea nitrogen and (B) plasma creatinine.
Values are means 5E. The number of animals used is indicated. *p <
0.01 compared with glycerol treatment alone. Abbreviations are: Cont,
control; CM, cimetidine; RN, ranitidine.
demonstrate a significant increase in levels of catalytic iron in the
kidneys of rats following glycerol injection, using an assay based
on the use of the antibiotic, bleomycin, to detect iron complexes
capable of catalyzing free radical reactions in biological samples
[9, 18—20]. This increase was specific to the kidneys as no similar
increase was observed in the liver. The bleomycin assay is based
on the observation that the anti-tumor antibiotic, bleomycin, in
the presence of an iron salt, binds to and degrades DNA with the
formation of a product that reacts with thiobarbituric acid. Iron
detected in this assay is thus a measure of iron available from the
biological sample for this reaction. Although other metal ions can
bind to bleomycin, they do not result in DNA degradation. The
assay conditions have been designed to prevent any interference
from iron proteins [18]. Iron bound to transferrin, lactoferrin,
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Control Cont+PB Glycerol +PB
Fig. 6. Effect of cytochrome P-450 inhibitors on glycerol-induced acute renal
failure as measured by (A) plasma urea nitrogen and (B) plasma creatinine.
Values are means SE. The number of animals used is indicated. *p <
0.01 compared with glycerol treatment alone. Abbreviations are: Cont,
control; PB, piperonyl butoxide.
ferritin or iron-containing enzymes does not register in the
bleomycin assay [18].
Since myoglobin released from injured muscles is rich in heme
iron, not surprisingly the current dogma is that myoglobin from
the muscle serves as the important source of iron in glycerol-
induced acute renal failure [7, 8, 12, 13]. We examined the
possibility that cytochrome P-450 may also serve as a source of
iron [16, 17]. If cytochrome P-450 serves as a source of heme iron
then this should result in the loss of cytochrome P-450. Indeed, we
found a marked decrease in cytochrome P-450 content in the
kidneys of the glycerol treated rats. This loss of cytochrome P-450
was specific to the kidneys as there was no difference in the levels
of cytochrome P-450 content in the liver between the glycerol and
control group of animals. The mechanism(s) responsible for this
loss in cytochrome P.450 are not known. However, hydrogen
peroxide and organic hydroperoxides have been shown to degrade
Group N
Histologic grade
0—trace I II III IV
Control 5 5
Glycerol 5 5
Glycerol + cimetidine 5 2 1 2
Renal tubule histologic grading is as follows: 0—trace, normal or mild
tubular cell swelling and/or vacuolar degeneration; I, areas of tubular
epithelial cell swelling, vacuolar degeneration, necrosis, and desquamation
involving <25% of cortical tubules; II, similar changes as grade I involving
>25% but <50%; III, similar changes as grade I involving >50% but
<75% of cortical tubules; IV, similar changes as grade I involving >75%
of cortical tubules.
hemoglobin and promote the release of iron from heme chelates
[9, 30]. In our previous studies we have demonstrated enhanced
generation of hydrogen peroxide in the kidneys in glycerol-
induced acute renal failure [31]. It is possible that such increased
generation of H202 could lead to direct oxidative attack on the
heme moiety of cytochrome P-450 promoting the release of this
iron from the labile heme chelate.
In previous studies of ischemia-reperfusion injury to lung and
kidney, an increase in low molecular weight iron or bleomycin
detectable iron, accompanied by a fall in cytochrome P-450 and
prevention of the increase in iron by cytochrome P-450 inhibitors,
has been taken as evidence to suggest that cytochrome P-450 is
the source of iron [16, 17]. In our study, cimetidine, which has
imidazole and cyano groups that inhibit cytochrome P-450 by
interacting with the heme iron [23], caused a marked reduction in
bleomycin-detectable iron in the kidneys, whereas ranitidine, a
weak inhibitor of cytochrome P-450 [23, 25], had no effect,
suggesting cytochrome P-450 as the source of iron. It has been
suggested that cytochrome P-450 inhibitors bind near the active
site of the enzyme rendering the heme iron unavailable [16]. One
possible mechanism is that the inhibitors may stabilize and protect
the enzyme from hydrogen peroxide generated in glycerol-in-
duced acute renal failure [31], thereby decreasing the destruction
of the heme chelate and the r'elease of its iron. This is supported
by our in vitro studies in which we have found that cytochrome
P-450 inhibitors prevented the release of iron in LLC-PK1 cells in
response to hydrogen peroxide (unpublished observations, manu-
script in preparation).
One would anticipate that if the heme moiety of cytochrome
P-450 serves as a source of this iron, then inhibitors that prevent
the increase in the bleomycin-detectable iron should also prevent
the loss of cytochrome P-450 in this model. We used two different
inhibitors of cytochrome P-450 to increase the specificity of our
observation. Both cimetidine and piperonyl butoxide (which yields
a metabolite that binds to heme iron of cytochrome P-450)
provided striking protection against the loss of cytochrome P-450.
Both the inhibitors of cytochrome P-450 also protected against
glycerol-induced acute renal failure. This functional protection
was associated with a reduction in the histological evidence of
renal damage. The protective effect of cytochrome P.450 inhibi-
tors did not appear to be due to their ability to reduce glycerol-
induced muscle damage as measured by serum aldolase levels. In
addition, the protective effect does not appear to be due to
cimetidine's effect on volume status [32].
Our data demonstrate that there is an increase in 'catalytic' iron
accompanied by a marked fall in cytochrome P-450 content in the
kidney in an animal model of myoglobinuric acute renal failure.
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Table 1. Semiquantitative analysis of renal tubule histology in ratsA
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Fig. 7. (A) Light-microscopy section of kidney from control rat showing no abnormalities (grade 0, periodic acid-Schiff stain X 200). (B) Light-microscopy
section of kidney from rat receiving glycerol alone showing massive tubular epithelial cell swelling, vacuolar degeneration, necrosis, and desquamation
involving> 75% of cortical tubules (grade IV, periodic acid-Schiff stain X 200). (C) Light-microscopy section of kidney from rat receiving glycerol plus
cimetidine showing areas of tubular epithelial cell swelling, vacuolar degeneration, necrosis, and desquamation involving < 25% of cortical tubules
(grade I, periodic acid-Schiff stain X 200).
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Inhibitors of cytochrome P-450 prevented the rise in the bleomy-
cm-detectable iron and prevented the loss of cytochrome P-450 in
this model of acute renal failure. In addition, inhibitors of
cytochrome P-450 provided functional and histological protection
in glycerol-induced acute renal failure. Taken together, our data
demonstrate that cytochrome P-450 plays an important role in
glycerol-induced acute renal failure, possibly by serving as a
source of catalytic iron. These data provide an unexpected finding
that cytochrome P-450 may serve as a source of iron in a model
where it is generally accepted that myoglobin from the released
skeletal muscle serves as a source of iron. In this regard it is
relevant that numerous experimental studies have demonstrated
that myoglobin has an inconsistent and relatively weak nephro-
toxic effect (for example in [2, 14]). Our data are also consistent
with recent studies that prior induction of heme oxygenase is
protective in a glycerol model of acute renal failure [71.The prior
induction of heme oxygenase would lead to rapid degradation of
released heme rendering the henie iron unavailable to participate
in oxidative stress. These results may have important clinical
implications because inhibitors of cytochrome P-450 may provide
protection in patients with rhabdomyolysis.
Fig. 8. Effect of cytochrome P.450 inhibitors on serum aldolase level in
glycerol model of acute renal ft,ilure. The assay was performed in five rats
from each group. Renal function in these subsets was not different from
the overall experimental groups (see Results). Values are means SE.
There was no statistical difference among glycerol alone, glycerol +
cimetidine (CM) and glycerol + piperonyl butoxide (PB) groups.
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